MV BioTherapeutics

usitransfer-usi_transfer_-_img_mv_biotherapeutics.jpeg

MV BioTherapeutics is a spin-off of the Institute for Research in Biomedicine (IRB, affiliated to USI) which was established in 2018, originally as MicroVaccines and later renamed MV BioTherapeutics. Its founder, Dr. Fabio Grassi (researcher and group leader at the IRB), has developed an innovative technology platform for the development of oral vaccines against intestinal infections, with the aim of addressing currently unresolved medical needs with high patient accessibility. In 2017, Grassi took the initial project, called EXEAD, to the then StartCup Ticino (now Boldbrain), coming in second in the finals. Since then, Fabio Grassi has incubated his startup at USI Startup Centre.

 

MV BioTherapeutics - homepage

Events
25
June
2022
25.
06.
2022
30
June
2022
30.
06.
2022

Device Accelerated solvers with PETSc: current status, future perspectives, and applications

Faculty of Biomedical Sciences, Faculty of Economics, Faculty of Informatics
01
July
2022
01.
07.
2022

Scalable Gaussian Processes

Faculty of Informatics
06
July
2022
06.
07.
2022